Healthcare provider profile · identity verified

Robert D. Roycroft, MD

Internal Medicine · CONCORD, NC · NPI 1417929126

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	442	113
Amlodipine Besylate	Amlodipine Besylate	416	102
Levothyroxine Sodium	Levothyroxine Sodium	398	89
Rosuvastatin Calcium	Rosuvastatin Calcium	356	95
Lisinopril	Lisinopril	344	83
Atorvastatin Calcium	Atorvastatin Calcium	335	91
Losartan Potassium	Losartan Potassium	282	69
Montelukast Sodium	Montelukast Sodium	258	47
Gabapentin	Gabapentin	251	63
Metoprolol Succinate	Metoprolol Succinate	219	45
Hydrochlorothiazide	Hydrochlorothiazide	194	49
Tamsulosin Hcl	Tamsulosin Hcl	180	44
Simvastatin	Simvastatin	177	41
Eliquis	Apixaban	164	31
Metformin Hcl Er	Metformin Hcl	164	43
Trazodone Hcl	Trazodone Hcl	148	34
Prednisone	Prednisone	146	89
Pravastatin Sodium	Pravastatin Sodium	143	33
Furosemide	Furosemide	142	46
Albuterol Sulfate Hfa	Albuterol Sulfate	124	37
Fluticasone Propionate	Fluticasone Propionate	124	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	122	15
Duloxetine Hcl	Duloxetine Hcl	120	29
Metoprolol Tartrate	Metoprolol Tartrate	118	31
Carvedilol	Carvedilol	106	30
Zolpidem Tartrate	Zolpidem Tartrate	106	20
Esomeprazole Magnesium	Esomeprazole Magnesium	104	23
Meloxicam	Meloxicam	104	26
Metformin Hcl	Metformin Hcl	101	24
Ozempic	Semaglutide	99	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	96	23
Potassium Chloride	Potassium Chloride	96	24
Mirtazapine	Mirtazapine	93	20
Finasteride	Finasteride	87	18
Pantoprazole Sodium	Pantoprazole Sodium	85	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	83	18
Sertraline Hcl	Sertraline Hcl	83	20
Lorazepam	Lorazepam	77	15
Tramadol Hcl	Tramadol Hcl	73	18
Citalopram Hbr	Citalopram Hydrobromide	70	14
Clopidogrel	Clopidogrel Bisulfate	70	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	13
Clonazepam	Clonazepam	66	11
Alprazolam	Alprazolam	61	suppressed
Allopurinol	Allopurinol	59	12
Famotidine	Famotidine	57	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	12
Celecoxib	Celecoxib	51	12
Quetiapine Fumarate	Quetiapine Fumarate	51	11
Testosterone Cypionate	Testosterone Cypionate	51	suppressed
Ezetimibe	Ezetimibe	48	13
Fenofibrate	Fenofibrate	48	suppressed
Buspirone Hcl	Buspirone Hcl	46	12
Cefdinir	Cefdinir	46	41
Escitalopram Oxalate	Escitalopram Oxalate	46	15
Olmesartan Medoxomil	Olmesartan Medoxomil	43	suppressed
Benazepril Hcl	Benazepril Hcl	41	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Januvia	Sitagliptin Phosphate	41	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	41	13
Hydralazine Hcl	Hydralazine Hcl	40	11
Glipizide Er	Glipizide	39	12
Donepezil Hcl	Donepezil Hcl	37	suppressed
Myrbetriq	Mirabegron	36	suppressed
Cephalexin	Cephalexin	35	28
Diazepam	Diazepam	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Spironolactone	Spironolactone	34	12
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Jardiance	Empagliflozin	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Torsemide	Torsemide	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	11
Propranolol Hcl	Propranolol Hcl	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Mounjaro	Tirzepatide	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Mometasone Furoate	Mometasone Furoate	25	12
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Rybelsus	Semaglutide	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Terbinafine Hcl	Terbinafine Hcl	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Glipizide	Glipizide	22	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	22	suppressed
Primidone	Primidone	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Glycopyrrolate	Glycopyrrolate	20	suppressed
Azithromycin	Azithromycin	19	17
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Nitroglycerin	Nitroglycerin	19	14
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Topiramate	Topiramate	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Metformin Er Gastric	Metformin Hcl	18	suppressed
Naproxen	Naproxen	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	16
Farxiga	Dapagliflozin Propanediol	17	suppressed
Mupirocin	Mupirocin	17	15
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Glimepiride	Glimepiride	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	15	suppressed
Clonidine	Clonidine	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Nexlizet	Bempedoic Acid/Ezetimibe	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Colchicine	Colchicine	14	suppressed
Desloratadine	Desloratadine	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Linzess	Linaclotide	14	suppressed
Risperidone	Risperidone	14	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lactulose	Lactulose	13	suppressed
Roflumilast	Roflumilast	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Temazepam	Temazepam	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Cymbalta	Duloxetine Hcl	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Guanfacine Hcl	Guanfacine Hcl	12	suppressed
Indomethacin Er	Indomethacin	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Livalo	Pitavastatin Calcium	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Vraylar	Cariprazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error